AI Automation ·
Should breast-screening AI be evaluated on reading time and recalls together?
Problem and evidence
Lunit announced that Stockholm would extend its AI as an independent second reader [1]. South Korea's prospective multicenter AI-STREAM cohort was conducted in the national screening setting, and the cited analysis is preliminary [2]. These stages and workflows differ, so estimates are not directly comparable. Detection and reading time alone can miss the burden of further testing and cancers diagnosed between rounds.
| Dimension | International case | South Korea |
|---|---|---|
| Adoption stage | Stockholm announced regional expansion after hospital use | South Korea published preliminary multicenter prospective findings from its screening setting |
| Evaluation focus | Use of AI as an independent second reader | Local decisions require tracking referrals and subsequent outcomes by facility |
Options and evaluation
A screening provider could retain two readers and add AI assistance, or pilot AI as the second reader with clinical arbitration on disagreements. Against each facility's baseline, record reading time, cancers detected, recalls, biopsy referrals and interval cancers found during follow-up. Limited follow-up capacity or substantial missing follow-up would justify pausing expansion.